Critical role of the WASF3 gene in JAK2/STAT3 regulation of cancer cell motility

Carcinogenesis

Volumn 34, Issue 9, 2013, Pages 1994-1999

  Teng, Yong ^a   Ghoshal, Pushpankur ^a   Ngoka, Lambert ^a   Mei, Yun ^a   Cowell, John K ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; JANUS KINASE 2; SHORT HAIRPIN RNA; STAT3 PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER LOCALIZATION; CELL ACTIVATION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; WASF2 GENE; WESTERN BLOTTING;

AMINOSALICYLIC ACIDS; BENZENESULFONATES; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; JANUS KINASE 2; MALE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROTEIN BINDING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY;

EID: 84882652678     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt167     Document Type: Article

References (32)

1. Nasr, Z. et al. (2012) Tumor progression and metastasis: role of translational deregulation. Anticancer Res., 32, 3077-3084.
2. Steeg, P.S. et al. (2003) Metastasis suppressor genes: basic biology and potential clinical use. Clin. Breast Cancer, 4, 51-62.
3. Adorno, M. et al. (2009) A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell, 137, 87-98.
4. Pollock, C.B. et al. (2005) Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells. Cancer Res., 65, 1244-1250.
5. Sossey-Alaoui, K. et al. (2005) WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp. Cell Res., 308, 135-145.
6. Sossey-Alaoui, K. et al. (2002) WAVE3, an actin-polymerization gene, is truncated and inactivated as a result of a constitutional t(1;13)(q21;q12) chromosome translocation in a patient with ganglioneuroblastoma. Oncogene, 21, 5967-5974.
7. Takenawa, T. et al. (2007) The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat. Rev. Mol. Cell Biol., 8, 37-48.
8. Sossey-Alaoui, K. et al. (2007) Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am. J. Pathol., 170, 2112-2121.
9. Teng, Y. et al. (2011) Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells. Int. J. Cancer, 129, 2825-2835.
10. Sossey-Alaoui, K. et al. (2005) WAVE3-mediated cell migration and lamellipodia formation are regulated downstream of phosphatidylinositol 3-kinase. J. Biol. Chem., 280, 21748-21755.
11. Lee, J.H. et al. (1997) Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res., 57, 2384-2387.
12. Jiang, Y. et al. (2005) KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin. Exp. Metastasis, 22, 369-376.
13. Cho, S.G. et al. (2009) KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation. J. Cell. Biochem., 107, 1139-1149.
14. Teng, Y. et al. (2013) WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells. Oncogene. doi:10.1038/onc.2012.565.
15. Sossey-Alaoui, K. et al. (2007) c-Abl-mediated phosphorylation of WAVE3 is required for lamellipodia formation and cell migration. J. Biol. Chem., 282, 26257-26265.
16. Prat, A. et al. (2010) Phenotypic and molecular characterization of the claudin- low intrinsic subtype of breast cancer. Breast Cancer Res., 12, R68.
17. Baldridge, M.T. et al. (2011) Inflammatory signals regulate hematopoietic stem cells. Trends Immunol., 32, 57-65.
18. Elsawa, S.F. et al. (2011) Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity. Blood, 118, 5540-5549.
19. Sullivan, N.J. et al. (2009) Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene, 28, 2940-2947.
20. Walter, M. et al. (2009) Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene, 28, 2745-2755.
21. Queen, M.M. et al. (2005) Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res., 65, 8896-8904.
22. Ara, T. et al. (2010) Interleukin-6 in bone metastasis and cancer progression. Eur. J. Cancer, 46, 1223-1231.
23. Teng, Y. et al. (2012) HSP90 and HSP70 proteins are essential for stabilization and activation of WASF3 metastasis-promoting protein. J. Biol. Chem., 287, 10051-10059.
24. Ghoshal, P. et al. (2012) Hypoxia-induced upregulation of the WASF3 metastasis associated gene leads to enhanced invasion in breast cancer cells. Int. J. Cancer, 129, 2825-2835.
25. Li, P. et al. (2010) Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells. PLoS One, 5, e11859.
26. Yu, H. et al. (2004) The STATs of cancer-new molecular targets come of age. Nat. Rev. Cancer, 4, 97-105.
27. Teng, Y. et al. (2010) Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases. Br. J. Cancer, 103, 1066-1075.
28. Buettner, R. et al. (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res., 8, 945-954.
29. Xiong, H. et al. (2012) Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer. J. Mol. Med. (Berl)., 90, 1037-1046.
30. Abdulghani, J. et al. (2008) Stat3 promotes metastatic progression of prostate cancer. Am. J. Pathol., 172, 1717-1728.
31. Gu, L. et al. (2010) Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth. Am. J. Pathol., 176, 1959-1972.
32. Yu, H. et al. (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer, 9, 798-809.